RAC 2.92% $1.94 race oncology ltd

Ann: Race Initiates FTO Directed Kidney Cancer Preclinical Study, page-13

  1. 2,369 Posts.
    lightbulb Created with Sketch. 457
    I do hope it will be a good outcome for patients treated with Bisantrene as the current drugs with a 5 year survival rate of 12% is very very low !!!
 
watchlist Created with Sketch. Add RAC (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.